HAVCR2 and neoplasm: As shown in Figure 6A, sequential administration of anti-PD-1 and anti-Tim-3 combined with the SA-GM-CSF-anchored vaccine (triple therapy) significantly suppressed tumor growth, and tumor regression was noted in over 50% of the treated mice.